MAPT and Alzheimer disease: Microglial activation constitutes a hallmark in the pathophysiology of Alzheimer’s disease (AD) [1] and has been associated with aggregation of misfolded β-amyloid (Aβ) and tau accumulation in patients with AD and in mouse models of AD [2].